Ypsomed Holding AG

The global medication adherence market is projected to grow from USD 6.08 billion in 2026 to USD 15.35 billion by 2035, at a compound annual growth rate of 10.92%, according to a new report from ResearchAndMarkets.com. The market's expansion is driven by rising chronic disease prevalence, an aging population, and adoption of digital health technologies. Software-centric solutions currently account for about 65% of the market, while hardware-centric solutions are expected to see faster growth. North America remains the largest regional market, with Asia-Pacific growing fastest. Key players include Medtronic, Roche, Insulet, Ypsomed, and 13 others.